BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36704211)

  • 1. Intraperitoneal Delivery of Iopamidol to Assess Extracellular pH of Orthotopic Pancreatic Tumor Model by CEST-MRI.
    Jardim-Perassi BV; Irrera P; Lau JYC; Budzevich M; Whelan CJ; Abrahams D; Ruiz E; Ibrahim-Hashim A; Damgaci Erturk S; Longo DL; Pilon-Thomas SA; Gillies RJ
    Contrast Media Mol Imaging; 2023; 2023():1944970. PubMed ID: 36704211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor pH Imaging Using Chemical Exchange Saturation Transfer (CEST)-MRI.
    Longo DL; Pirotta E; Gambino R; Romdhane F; Carella A; Corrado A
    Methods Mol Biol; 2023; 2614():287-311. PubMed ID: 36587132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Nanoscale Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Contrast Agent That Measures pH.
    Kombala CJ; Kotrotsou A; Schuler FW; de la Cerda J; Ma JC; Zhang S; Pagel MD
    ACS Nano; 2021 Dec; 15(12):20678-20688. PubMed ID: 34870957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pH.
    Moon BF; Jones KM; Chen LQ; Liu P; Randtke EA; Howison CM; Pagel MD
    Contrast Media Mol Imaging; 2015; 10(6):446-55. PubMed ID: 26108564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A machine learning approach that measures pH using acidoCEST MRI of iopamidol.
    Li T; Cárdenas-Rodríguez J; Trakru PN; Pagel MD
    NMR Biomed; 2023 Oct; 36(10):e4986. PubMed ID: 37280721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of iopamidol multi-site chemical exchange properties for ratiometric chemical exchange saturation transfer (CEST) imaging of pH.
    Sun PZ; Longo DL; Hu W; Xiao G; Wu R
    Phys Med Biol; 2014 Aug; 59(16):4493-504. PubMed ID: 25054859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI.
    Chen LQ; Howison CM; Jeffery JJ; Robey IF; Kuo PH; Pagel MD
    Magn Reson Med; 2014 Nov; 72(5):1408-17. PubMed ID: 24281951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitor Tumor pHe and Response Longitudinally during Treatment Using CEST MRI-Detectable Alginate Microbeads.
    Xiao P; Huang J; Han X; Cheu JWS; Liu Y; Law LH; Lai JHC; Li J; Park SW; Wong CCL; Lam RHW; Chan KWY
    ACS Appl Mater Interfaces; 2022 Dec; 14(49):54401-54410. PubMed ID: 36448714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo pH.
    Lindeman LR; Randtke EA; High RA; Jones KM; Howison CM; Pagel MD
    Magn Reson Med; 2018 May; 79(5):2766-2772. PubMed ID: 29024066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a similarity anisotropic diffusion denoising approach for improving in vivo CEST-MRI tumor pH imaging.
    Romdhane F; Villano D; Irrera P; Consolino L; Longo DL
    Magn Reson Med; 2021 Jun; 85(6):3479-3496. PubMed ID: 33496986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multislice CEST MRI improves the spatial assessment of tumor pH.
    Randtke EA; Granados JC; Howison CM; Pagel MD; Cárdenas-Rodríguez J
    Magn Reson Med; 2017 Jul; 78(1):97-106. PubMed ID: 27465207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A generalized ratiometric chemical exchange saturation transfer (CEST) MRI approach for mapping renal pH using iopamidol.
    Wu Y; Zhou IY; Igarashi T; Longo DL; Aime S; Sun PZ
    Magn Reson Med; 2018 Mar; 79(3):1553-1558. PubMed ID: 28686805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fast multislice sequence for 3D MRI-CEST pH imaging.
    Villano D; Romdhane F; Irrera P; Consolino L; Anemone A; Zaiss M; Dastrù W; Longo DL
    Magn Reson Med; 2021 Mar; 85(3):1335-1349. PubMed ID: 33031591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEST-MRI for glioma pH quantification in mouse model: Validation by immunohistochemistry.
    Ferrauto G; Di Gregorio E; Auboiroux V; Petit M; Berger F; Aime S; Lahrech H
    NMR Biomed; 2018 Nov; 31(11):e4005. PubMed ID: 30256478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of Iopamidol-based quantitative pH imaging on a clinical 3T MR scanner.
    Müller-Lutz A; Khalil N; Schmitt B; Jellus V; Pentang G; Oeltzschner G; Antoch G; Lanzman RS; Wittsack HJ
    MAGMA; 2014 Dec; 27(6):477-85. PubMed ID: 24570337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Imaging of Tumor Metabolism and Acidosis by Combining PET and MRI-CEST pH Imaging.
    Longo DL; Bartoli A; Consolino L; Bardini P; Arena F; Schwaiger M; Aime S
    Cancer Res; 2016 Nov; 76(22):6463-6470. PubMed ID: 27651313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AcidoCEST MRI Evaluates the Bone Microenvironment in Multiple Myeloma.
    Lombardi AF; Wong JH; High R; Ma Y; Jerban S; Tang Q; Du J; Frost P; Pagel MD; Chang EY
    Mol Imaging Biol; 2021 Dec; 23(6):865-873. PubMed ID: 33939066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring in vivo tumor pHe with CEST-FISP MRI.
    Sheth VR; Li Y; Chen LQ; Howison CM; Flask CA; Pagel MD
    Magn Reson Med; 2012 Mar; 67(3):760-8. PubMed ID: 22028287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iopamidol: Exploring the potential use of a well-established x-ray contrast agent for MRI.
    Aime S; Calabi L; Biondi L; De Miranda M; Ghelli S; Paleari L; Rebaudengo C; Terreno E
    Magn Reson Med; 2005 Apr; 53(4):830-4. PubMed ID: 15799043
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.